| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.55.10.1299 |
| P8608 | Fatcat ID | release_6pcoushaczc73floqqbwukram4 |
| P698 | PubMed publication ID | 9779656 |
| P50 | author | Iscia Lopes-Cendes | Q42419183 |
| Guy A. Rouleau | Q3121500 | ||
| P2093 | author name string | Furukawa Y | |
| Guttman M | |||
| Nance M | |||
| Ang L | |||
| Kish SJ | |||
| Schut L | |||
| Ross BM | |||
| Pandolfo M | |||
| DiStefano L | |||
| P433 | issue | 10 | |
| P304 | page(s) | 1299-1304 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders | |
| P478 | volume | 55 |
| Q38998405 | AMPK in Neurodegenerative Diseases |
| Q28214631 | Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? |
| Q43991317 | Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts |
| Q30586618 | An integrated strategy for evaluation of metabolic and oxidative defects in neurodegenerative illness using magnetic resonance techniques |
| Q34460105 | Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? |
| Q41522392 | Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis |
| Q34991055 | Glucose/mitochondria in neurological conditions |
| Q43094359 | Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington's disease mice |
| Q42472433 | Huntington's disease and mitochondrial alterations: emphasis on experimental models |
| Q45290567 | Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice |
| Q34480379 | Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH |
| Q33181556 | Neurotoxicity of advanced glycation end-products for cultured cortical neurons |
| Q30322264 | New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. |
| Q44400915 | Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington’s disease |
| Q35092256 | Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs |
| Q32034809 | Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts |
| Q36076365 | Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment |
| Q44852327 | Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers |
| Q28609410 | The alpha-ketoglutarate dehydrogenase complex |
Search more.